Decentralized N=1 Study: A Feasible Approach to Evaluate Individual Therapy Response to Dapagliflozin.
Conditions: Diabetes Mellitus, Type 2; Diabetes Mellitus Type 2 With Proteinuria; Diabetes Mellitus; Diabetes; Diabetes Complications; Albuminuria; Chronic Kidney Diseases; Chronic Kidney Disease Due to Type 2 Diabetes Mellitus; CKD; Proteinuria Interventions: Drug: Dapagliflozin 10mg Tab; Drug: Placebo; Device: Withings BPM Connect; Device: Withings Body+; Diagnostic Test: Hem-Col Capillary Blood Collection Device; Device: MEMS (Medication Electronic Monitoring System) Cap; Behavioral: Questionnaire: participants ' perspectives toward remote data collection Sponsors: University Medical Center Groningen; AstraZeneca Comple...
Source: ClinicalTrials.gov - April 18, 2024 Category: Research Source Type: clinical trials
MASLD in Primary Hypothyroidism and Efficacy of Dapaglifozin
Conditions: Hepatic Steato-Fibrosis; Non-Alcoholic Fatty Liver Disease Interventions: Drug: Dapagliflozin 10mg Tab; Drug: Placebo; Drug: Levothyroxine Replacement daily Sponsors: Post Graduate Institute of Medical Education and Research, Chandigarh Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 18, 2024 Category: Research Source Type: clinical trials
The Efficacy and Safety of Dapagliflozin in Improving Heart Failure in Dialysis Patients
Conditions: The Efficacy and Safety of Dapagliflozin in Improving Heart Failure in Dialysis Patients Interventions: Drug: Dapagliflozin Sponsors: The People ' s Hospital of Gaozhou Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 15, 2024 Category: Research Source Type: clinical trials
SGLT2i to Prevent of Liver Complications in Patients With CHB and Diabetes Mellitus
Conditions: Chronic Hepatitis B Interventions: Drug: Dapagliflozin 10mg Tab; Drug: Placebo 10mg Tab Sponsors: Chinese University of Hong Kong Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 15, 2024 Category: Research Source Type: clinical trials
Efficacy, Safety and Tolerability of Balcinrenone/Dapagliflozin Compared to Dapagliflozin in Adults With Chronic Kidney Disease.
Conditions: Chronic Kidney Disease Interventions: Drug: Balcinrenone/dapagliflozin 15 mg/10 mg and matching placebo for dapagliflozin 10 mg; Drug: Balcinrenone/dapagliflozin 40 mg/10 mg and matching placebo for dapagliflozin 10 mg; Drug: Dapagliflozin 10 mg and matching placebo for balcinrenone/dapa gliflozin Sponsors: AstraZeneca Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 5, 2024 Category: Research Source Type: clinical trials
Potential Protective Role of SGLT-2 Inhibitors for Chemotherapy-induced Cardiotoxicity
Conditions: Breast Cancer Interventions: Drug: Dapagliflozin 10mg Tab Sponsors: Fondazione IRCCS Policlinico San Matteo di Pavia Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 2, 2024 Category: Research Source Type: clinical trials
Real-world Study on Dapagliflozin Usage in Patients With Heart Failure (HF) in Germany
Conditions: Heart Diseases; Cardiovascular Diseases; Heart Failure Sponsors: AstraZeneca Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 28, 2024 Category: Research Source Type: clinical trials
Efficacy of FDC Regimen of Dapagliflozin/Metformin Compared to Co-administered Dual Therapy on Glycemic Control, Satisfaction and Adherence in Chinese Patients With T2DM
Conditions: Type 2 Diabetes Mellitus (T2DM) Interventions: Drug: Xigduo (Dapagliflozin and Metformin hydrochloride extended-release) tablets; Drug: Dapagliflozin tablets and Metformin HCl extended-release tablets Sponsors: AstraZeneca Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 25, 2024 Category: Research Source Type: clinical trials
Impact of Dapagliflozin as Add-on Therapy on Glycemic Status and Quality of Life in Type 2 Diabetic Patients
Conditions: Diabetic Nephropathy Type 2 Interventions: Drug: Dapagliflozin Sponsors: Mohammed Mahmood Mohammed Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 22, 2024 Category: Research Source Type: clinical trials
Optimising Metabolic Management for People With Human Immunodeficiency Virus (HIV) on Integrase Based Antiretroviral Therapy (ART)
Conditions: HIV Infections; Weight Gain Interventions: Drug: Dapagliflozin 10mg Tab; Drug: Pitavastatin 4 Mg Oral Tablet; Drug: Rosuvastatin and Ezetimibe; Drug: Placebo Sponsors: Kirby Institute Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 19, 2024 Category: Research Source Type: clinical trials
Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function
Conditions: Heart Failure and Impaired Kidney Function Interventions: Drug: balcinrenone/dapagliflozin 15 mg/10 mg and matching placebo for dapagliflozin 10 mg; Drug: balcinrenone/dapagliflozin 40 mg/10 mg and matching placebo for dapagliflozin 10 mg; Drug: dapagliflozin 10 mg and matching placebo for balcinrenone/dapa gliflozin Sponsors: AstraZeneca Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 13, 2024 Category: Research Source Type: clinical trials
CardioPROTECTion With Dapagliflozin in Breast Cancer Patients Treated With AnthrAcycline - PROTECTAA TRIAL
Conditions: Breast Cancer; Heart Failure Interventions: Drug: Dapagliflozin; Drug: Placebo Sponsors: 4th Military Clinical Hospital with Polyclinic, Poland Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 11, 2024 Category: Research Source Type: clinical trials
Combination of Daratumumab and BD Regimen and Dapagliflozin in the Treatment of M-protein Related Cardiac Disease
Conditions: M-protein Related Cardiac Disease Interventions: Drug: Daratumumab + Bortezomib + Dexamethasone + Dapagliflozin Sponsors: Beijing Chao Yang Hospital; Beijing Chuiyangliu Hospital; Beijing Boren Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 7, 2024 Category: Research Source Type: clinical trials
Pleiotropic Effects of Dapagliflozin in Patients With Acute Coronary Syndromes
Conditions: Myocardial Infarction; Acute Coronary Syndrome; Diabetes; Ventricular Dysfunction Interventions: Drug: Placebo; Drug: Dapagliflozin Sponsors: University of Sao Paulo Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 29, 2024 Category: Research Source Type: clinical trials
Effect of Low Protein Diet on Top of Dapagliflozin on Chronic Kidney Disease in Patients With Type 2 Diabetes Mellitus
Conditions: Chronic Kidney Diseases; Type 2 Diabetes Mellitus Interventions: Drug: Dapagliflozin 10 mg Tab; Behavioral: Low protein diet Sponsors: Anemia Working Group Romania; Sf Ioan Emergency Clinical Hospital, Nephrology and Dialysis Department, Bucharest, Romania; Dr Carol Davila Teaching Hospital of Nephrology, Nephrology Department, Bucharest, Romania; Carol Davila University of Medicine and Pharmacy Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 28, 2024 Category: Research Source Type: clinical trials
